John Bartholomew, MD, is Section Head of Vascular Medicine and a staff physician in the Sydell and Arnold Miller Family Heart & Vascular Institute. He has a joint appointment to the Department of Hematology/Oncology. He is board-certified as a Diplomate of the American Board of Internal Medicine and the American Board of Vascular Medicine.
Dr. Bartholomew's specialty interests include clotting disorders (acquired and inherited), such as heparin-induced thrombocytopenia, antiphospholipid syndrome, thrombosis in cancer patients, protein C and S deficiencies, antithrombin deficiency and prothrombin gene mutation and Factor V Leiden as well as elevated factor VIII and homocysteine levels. In addition, Dr. Bartholomew's other clinical interests include peripheral arterial disease, lymphedema, thromboembolism (deep vein thrombosis and pulmonary embolism), leg ulcers and varicose and spider veins that he treats with sclerotherapy.
He did his undergraduate work at Central Michigan University. He received his medical degree from the Autonomous Universidad De Guadalajara, in Guadalajara, Jalisco, Mexico. He completed his internship and residency at Maryland General Hospital in Baltimore, where he was Chief Resident. He was awarded a fellowship by the Johns Hopkins Hospital and appointed Senior Clinical Fellow in the Division of Hematology. While at Johns Hopkins, he received the William Bell Award for Patient Care.
Prior to joining the Cleveland Clinic in 1989, Dr. Bartholomew was the Assistant Director of Internal Medicine Education at St. Joseph Hospital at Michigan State University, where he was given the Instructor of the Year Award for the Family Practice Residency Program. He also served as Director of the Eastern Michigan Hemophilia Center.
Dr. Bartholomew holds academic appointments at Penn State University and Ohio College of Podiatric Medicine. He also serves as Program Director for the Section of Vascular Medicine and is director of the Vascular Medicine Section’s coumadin clinic. In 2003, Dr. Bartholomew became part of the clinical faculty for the Joint Commission Resources, Inc., for the Joint Commission on Accreditation of Hospital Organizations (JCAHO). He has also been a member of the Deep Vein Thrombosis Steering Committee for the National Quality Forum, which sets the national standards for the care of patients with Deep Vein Thrombosis and Pulmonary Embolism.
Dr. Bartholomew was voted one of Cleveland's Best Doctor's by Cleveland Magazine in 2007, 2006, 2004, 2002, 2001 and 1998. In 2001, he was named Teacher of the Year by Cleveland Clinic’s Department of Vascular Medicine.
He has published numerous articles and abstracts in professional scientific journals including the Annals of Internal Medicine, Transfusion, Cardiovascular Surgery, Circulation, the Cleveland Clinic Journal of Medicine, Chest, Archives of Internal Medicine, Journal of Pediatrics, and Vascular Medicine on topics related to smokeless tobacco and cardiovascular risk, peripheral artery disease, pulmonary embolism, and heparin-induced thrombocytopenia and deep vein thrombosis, among others. He has authored more than 30 chapters in medical textbooks related to atheromatous embolization, stasis leg ulcers, hypercoagulable states, heparin-induced thrombocytopenia, and peripheral arterial disease.
Dr. Bartholomew has been an invited speaker at workshops, symposiums and conferences on the diagnosis and treatment of deep vein and pulmonary embolism, peripheral arterial disease and the diagnosis and management of patients with hypercoagulable states and the diagnosis and treatment of heparin-induced thrombocytopenia.
He is a fellow of the Society of Vascular Medicine and Biology, a fellow of the American College of Cardiology, a fellow of the International Academy of Clinical and Applied Thrombosis and Hemostasis. He is a member of the American College of Physicians, the Johns Hopkins Medical and Surgical Society, the American Society of Hematology and the International Society of Thrombosis and Hemostasis.
Thrombolytic therapy, atheromatous embolization, hypercoagulable disorders, venous disorders, sclerotherapy, peripheral arterial disease, pulmonary artery disease, unusual vascular disorders.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
